Gorka San José

Gorka San José

Auto-generated profile, based on publicly available information

Gorka San José

Division of Cardiovascular Sciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2001 in Hypertension
Verified
Journal Article
Closed access
PDF file
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba
GJGorka San José
Gorka San José
MMMaría U. Moreno
María U. Moreno
MFMaría A. Fortuño
María A. Fortuño
AFAna Fortuño
Ana Fortuño
JDJavier DíeZ
Javier DíeZ
Increased vascular reactive oxygen species production, especially superoxide anion, contributes significantly in the functional and structural alterations present in hypertension. An enhanced superoxide production causes a diminished NO bioavailability by an oxidative reaction that inactivates NO. Exaggerated superoxide levels and a low NO bioavailability lead to endothelial dysfunction and hypertrophy of vascular cells. It has been shown that the enzyme NAD(P)H oxidase plays a major role as the most important source of superoxide anion in vascular cells. Several experimental observations have shown an enhanced superoxide generation as a result of the activation of vascular NAD(P)H oxidase in hypertension. Although this enzyme responds to stimuli such as vasoactive factors, growth factors, and cytokines, some recent data suggest the existence of a genetic background modulating the expression of its different components. New polymorphisms have been identified in the promoter of the p22 phox gene, an essential subunit of NAD(P)H oxidase, influencing the activity of this enzyme. Genetic investigations of these polymorphisms will provide novel markers for determination of genetic susceptibility to oxidative stress in hypertension.

1 May 2000 in Hypertension
Verified
Journal Article
Closed access
PDF file
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba
FBFrancisco J. Beaumont
Francisco J. Beaumont
GJGorka San José
Gorka San José
AFAna Fortuño
Ana Fortuño
MFMaría A. Fortuño
María A. Fortuño
JDJavier DíeZ
Javier DíeZ
—This study was designed to test the hypothesis that stimulation of nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) oxidase is involved in increased vascular superoxide anion (·O 2 − ) production in spontaneously hypertensive rats (SHR). The study was performed in 16-week-old and 30-week-old normotensive Wistar-Kyoto rats (WKY 16 and WKY 30 , respectively) and in 16-week-old and 30-week-old SHR (SHR 16 and SHR 30 , respectively). In addition, 16-week-old SHR were treated with oral irbesartan (average dose 20 mg/kg per day) for 14 weeks (SHR 30 -I). Aortic NADH/NADPH oxidase activity was determined by use of chemiluminescence with lucigenin. The expression of p22phox messenger RNA was assessed by competitive reverse transcription–polymerase chain reaction. Vascular responses to acetylcholine were determined by isometric tension studies. Aortic wall structure was studied, determining the media thickness and the cross-sectional area by morphometric analysis. Whereas systolic blood pressure was significantly increased in the 2 groups of hypertensive animals compared with their normotensive controls, no differences were observed in systolic blood pressure between SHR 30 and SHR 16 . No other differences in the parameters measured were found between WKY 16 and SHR 16 . In SHR 30 compared with WKY 30 , we found significantly greater p22phox mRNA level, NADH/NADPH-driven ·O 2 − production, media thickness, and cross-sectional area and an impaired vasodilation in response to acetylcholine. Treated SHR had similar NADH/NADPH oxidase activity and p22phox expression as the WKY 30 group. The vascular functional and morphological parameters were improved in SHR 30 -I. These findings suggest that an association exists between p22phox gene overexpression and NADH/NADPH overactivity in the aortas of adult SHR. Enhanced NADH/NADPH oxidase–dependent ·O 2 − production may contribute to endothelial dysfunction and vascular hypertrophy in this genetic model of hypertension.

1 June 2015 in JACC
Verified
Journal Article
Closed access
BLBegoña López
Begoña López
AGArantxa González
Arantxa González
SRSusana Ravassa
Susana Ravassa
JBJavier Beaumont
Javier Beaumont
MMMaría U. Moreno
María U. Moreno
JDJavier Díez
Javier Díez

1 September 2018 in Hypertension
Verified
Journal Article
Closed access
AGArantxa González
Arantxa González
SRSusana Ravassa
Susana Ravassa
BLBegoña López
Begoña López
MMMaría U. Moreno
María U. Moreno
JBJavier Beaumont
Javier Beaumont
JDJavier Díez
Javier Díez

1 January 2016 in JACC
Verified
Journal Article
Closed access
BLBegoña López
Begoña López
SRSusana Ravassa
Susana Ravassa
AGArantxa González
Arantxa González
EZElena Zubillaga
Elena Zubillaga
CBClaudia Bonavila
Claudia Bonavila
JDJavier Díez
Javier Díez

13 July 2005 in Experimental Physiology
Verified
Journal Article
Closed access
AFAna Fortuño
Ana Fortuño
GJGorka San José
Gorka San José
MMMaría U. Moreno
María U. Moreno
JDJavier Díez
Javier Díez
Guillermo ZalbaGuillermo Zalba
Guillermo Zalba